PRAC recommends new measures to minimise risk of rare but serious liver injury with Esmya for fibroids

View source ↗

Summary

The Pharmacovigilance Risk Assessment Committee (PRAC) recommends new measures to minimize the risk of rare but serious liver injury with Esmya (ulipristal acet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Esmya (ulipristal acetate)